Hinduja Global Solutions (HGS) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
2 Nov, 2026Executive summary
FY26 revenue from operations was INR 4,307.4 crore, down 2.2% YoY; EBITDA was INR 648.6 crore, down 20.1%, at a 13.4% margin.
Continuing operations recorded a net loss of INR 143.08 crore; reported net profit was INR 4.94 crore, including INR 148.02 crore from discontinued operations.
FY26 focused on portfolio rebalancing, cost rationalization and an integrated Intelligent Experience strategy; management cited 79 record new wins and potential for a stronger FY27.
Financial highlights
Q4 revenue from operations was INR 1,084.7 crore, down 6.6% YoY and up 0.9% QoQ; total income was INR 1,254.6 crore.
Q4 EBITDA was INR 197.1 crore, up 47.4% QoQ, with a 15.7% margin versus 11.2% in Q3 and 21.5% in Q4 FY25.
Q4 reported net loss was INR 13.58 crore, versus profit of INR 34.4 crore in Q3 and loss of INR 1.7 crore in Q4 FY25.
Standalone FY26 revenue was INR 1,827.12 crore and net loss INR 160.58 crore; basic EPS was negative INR 34.52.
Outlook and guidance
Management expects steady improvement in growth and margins, while remaining cautious amid macro uncertainty and near-term client caution.
Record 79 FY26 wins and a strong pipeline support FY27 revenue visibility; sales opportunities are increasingly moving from PoCs to 90-day PoVs.
AI and digital contributions are expected to grow as signings ramp and AI assistants enter production; Agent X had 21 AI assistants in production.
FY26 cost actions are expected to flow through during H1 FY27; negative EPS is expected to improve as AI delivery and broadband investments mature, with no quantified timeline.
Latest events from Hinduja Global Solutions
- Q2 operating EBITDA rose 30% as cost discipline offset muted growth.HGS
Q2 23/24 - Q3 EBITDA surged and PBT turned positive amid digital growth and uncertain demand.HGS
Q3 23/24 - FY2024 operating EBITDA rose 45.8% as AI-led growth advanced amid unresolved tax-search exposure.HGS
Q4 23/24 - One-time costs pressured margins; healthcare-sale gain lifted PAT, with recovery expected from Q2.HGS
Q1 24/25 - UK and macro headwinds cut revenue as technology and AI initiatives advanced.HGS
Q2 24/25 - FY25 PAT included a healthcare-sale gain as strategy pivots to AI-led digital growth.HGS
Q4 24/25 - Q3 EBITDA margin reached 19% as AI-led growth advanced amid near-term revenue pressure.HGS
Q3 24/25 - Margin expansion and digital traction amid softer Q1 revenue.HGS
Q1 25/26 - Revenue held broadly steady as continuing losses widened; client wins and Project GANGA advanced.HGS
Q1 26/27